Group Press Releases
Interim Management Statement
30 April 2008
Trading across the group to date has remained healthy since the start of the year and we continue to expect to make good progress on an underlying basis at constant currency in the current financial year.
Group organic revenue growth was 8.3% in the first quarter, ahead of the wider marketing communications industry, and total revenue growth at constant currency was 15.3%.
|
Revenue growth |
Organic | Total, constant currency | Total, reported rates |
|---|---|---|---|
|
Aegis Media |
10.3% | 19.4% | 29.9% |
|
Synovate |
5.0% | 9.1% | 16.5% |
|
Aegis Group |
8.3% | 15.3% | 24.1% |
Our financial position remains robust. In the year to date we have made six acquisitions, representing a total of £11.7m in upfront cash payments and a further £15.1m in deferred consideration.
Aegis Media
This reflects a strong first quarter at Aegis Media, with organic revenue growth of 10.3% and total revenue growth at constant currency of 19.4%. A market-leading position in digital services, expansion of existing client relationships and good net new business won in 2007, including Johnson & Johnson in EMEA and Mattel globally, have helped drive this performance. Growth in each region was once again ahead of the wider market.
Account wins in the first quarter included the AA and Sky by Isobar UK, The Telegraph by Carat UK, Cofidis and Portugal Telecom Mobile by Carat Portugal, Seagate by Carat USA, Suzuki by Vizeum Canada, Kraft by Carat China and Beiersdorf by Carat Hong Kong and Indonesia.
Aegis Media acquisitions included White Sheep in Finland, completing the Suddenly full-service Nordics digital network, JJP in sponsorship and experiential marketing in Sweden and Checkit in search in the Netherlands.
Synovate
Organic revenue growth at Synovate was 5.0% in the first quarter and total revenue growth at constant currency was 9.1%. Demand remains healthy across all regions. Growth in current year sales orders was ahead of revenue growth, underpinning our confidence in a further year of market outperformance at Synovate.
In Synovate we acquired CIMA Group, establishing us in Latin America, Oncology Inc., boosting Synovate Healthcare’s existing strength in oncology therapy monitor and PS&A, continuing our expansion of the Synovate Aztec brand and technology in retail scan data.
For further information contact:
Charlotte Elston / Hannah Bailey
Aegis Group plc
+44 (0) 20 7070 7708 / 7725
Tim Spratt / Charles Palmer
Financial Dynamics
+44 (0) 20 7831 3113
